Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients

被引:61
作者
Peters, Lars [1 ]
Grint, Daniel [2 ]
Lundgren, Jens D. [3 ]
Rockstroh, Jurgen K. [4 ]
Soriano, Vincent [5 ]
Reiss, Peter [6 ]
Grzeszczuk, Anna [7 ]
Sambatakou, Helen [8 ]
Mocroft, Amanda [2 ]
Kirk, Ole [3 ]
机构
[1] Univ Copenhagen, Fac Hlth Sci, Panum Inst, Copenhagen HIV Programme, DK-2200 Copenhagen, Denmark
[2] UCL, Sch Med, Res Dept Infect & Populat Hlth, Div Populat Hlth, London W1N 8AA, England
[3] Rigshosp, Dept Infect Dis, DK-2100 Copenhagen, Denmark
[4] Univ Bonn, Dept Med 1, Bonn, Germany
[5] Hosp Carlos III, Madrid, Spain
[6] Univ Amsterdam, Acad Ziekenhuis, Amsterdam, Netherlands
[7] Med Univ Bialystok, Dept Infect Dis, Bialystok, Poland
[8] Univ Athens, Ippokrat Gen Hosp, Athens, Greece
基金
瑞士国家科学基金会;
关键词
coinfection; hepatitis C virus; HIV; kidney disease; viremia; GLOMERULAR-FILTRATION-RATE; SERUM CREATININE; PREVALENCE; CRYOGLOBULINEMIA; COINFECTION; PREDICTION; THERAPY; AIDS;
D O I
10.1097/QAD.0b013e3283574e71
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Several studies have reported on an association between hepatitis C virus (HCV) antibody status and the development of chronic kidney disease (CKD), but the role of HCV viremia and genotype are not well defined. Methods: Patients with at least three serum creatinine measurements after 1 January 2004 and known HCV antibody status were included. Baseline was defined as the first eligible estimated glomerular filtration rate (eGFR) (Cockcroft-Gault equation), and CKD was either a confirmed (>3 months apart) eGFR of 60 ml/min per 1.73 m(2) or less for patients with a baseline eGFR more than 60 ml/min per 1.73 m(2) or a confirmed 25% decline in eGFR for patients with a baseline eGFR of 60 ml/min per 1.73 m(2) or less. Incidence rates of CKD were compared between HCV groups (anti-HCV-negative, anti-HCV-positive with or without viremia) using Poisson regression. Results: Of 8235 patients with known anti-HCV status, 2052 (24.9%) were anti-HCV-positive of whom 983 (47.9%) were HCV-RNA-positive, 193 (9.4%) HCV-RNA-negative and 876 (42.7%) had unknown HCV-RNA. At baseline, the median eGFR was 97.6 (interquartile range 83.8-113.0) ml/min per 1.73 m(2). During 36123 person-years of follow-up (PYFU), 495 patients progressed to CKD (6.0%) with an incidence rate of 14.5 per 1000 PYFU (95% confidence interval 12.5-14.9). In a multivariate Poisson model, patients who were anti-HCV-positive with HCV viremia had a higher incidence rate of CKD, whereas patients with cleared HCV infection had a similar incidence rate of CKD compared with anti-HCV-negative patients. There was no association between CKD and HCV genotype. Conclusion: Compared with HIV-monoinfected patients, HIV-positive patients with chronic rather than cleared HCV infection were at increased risk of developing CKD, suggesting a contribution from active HCV infection toward the pathogenesis of CKD. (C) 2012 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins
引用
收藏
页码:1917 / 1926
页数:10
相关论文
共 20 条
[1]   Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy [J].
Arase, Yasuji ;
Suzuki, Fumitaka ;
Kawamura, Yusuke ;
Suzuki, Yoshiyuki ;
Kobayashi, Masahiro ;
Matsumoto, Naoki ;
Akuta, Norio ;
Sezaki, Hitomi ;
Hosaka, Tetsuya ;
Ogawa, Kyoko ;
Imai, Norihiro ;
Seko, Yuya ;
Saito, Satoshi ;
Ikeda, Kenji ;
Kobayashi, Mariko ;
Kumada, Hiromitsu .
HEPATOLOGY RESEARCH, 2011, 41 (10) :946-954
[2]   Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the Multicenter AIDS Cohort Study [J].
Brown, TT ;
Cole, SR ;
Li, XH ;
Kingsley, LA ;
Palella, FJ ;
Riddler, SA ;
Visscher, BR ;
Margolick, JB ;
Dobs, AS .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (10) :1179-1184
[3]   HCV Infection and the Incidence of CKD [J].
Butt, Adeel A. ;
Wang, Xiaoqiang ;
Fried, Linda F. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2011, 57 (03) :396-402
[4]   Detection of the hepatitis C virus antigen in kidney tissue from infected patients with various glomerulonephritis [J].
Cao, Yali ;
Zhang, Youkang ;
Wang, Suxia ;
Zou, Wanzhong .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (09) :2745-2751
[5]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[6]   Hypertension among HIV patients: prevalence and relationships to insulin resistance and metabolic syndrome [J].
Gazzaruso, C ;
Bruno, R ;
Garzaniti, A ;
Giordanetti, S ;
Fratino, P ;
Sacchi, P ;
Filice, G .
JOURNAL OF HYPERTENSION, 2003, 21 (07) :1377-1382
[7]   Hepatorenal syndrome [J].
Ginès, P ;
Guevara, M ;
Arroyo, V ;
Rodés, J .
LANCET, 2003, 362 (9398) :1819-1827
[8]   Modification of the CKD Epidemiology Collaboration (CKD-EPI) Equation for Japanese: Accuracy and Use for Population Estimates [J].
Horio, Masaru ;
Imai, Enyu ;
Yasuda, Yoshinari ;
Watanabe, Tsuyoshi ;
Matsuo, Seiichi .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (01) :32-38
[9]   Chronic nephropathies of cocaine and heroin abuse: A critical review [J].
Jaffe, Jared A. ;
Kimmel, Paul L. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (04) :655-667
[10]   Prevalence of cryoglobulinaemia in hepatitis C virus- and hepatitis C virus/human immunodeficiency virus-infected individuals: implications for renal function [J].
Lapinski, Tadeusz Wojciech ;
Parfieniuk, Anna ;
Rogalska-Plonska, Magdalena ;
Czajkowska, Jolanta ;
Flisiak, Robert .
LIVER INTERNATIONAL, 2009, 29 (08) :1158-1161